• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在自然发生的犬类模型中,循环外泌体微小RNA与黏液瘤样二尖瓣疾病继发的心力衰竭相关。

Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model.

作者信息

Yang Vicky K, Loughran Kerry A, Meola Dawn M, Juhr Christine M, Thane Kristen E, Davis Airiel M, Hoffman Andrew M

机构信息

Department of Clinics Sciences, Tufts University Cummings School of Veterinary Medicine, North Grafton, USA.

出版信息

J Extracell Vesicles. 2017 Jul 12;6(1):1350088. doi: 10.1080/20013078.2017.1350088. eCollection 2017.

DOI:10.1080/20013078.2017.1350088
PMID:28804599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5533140/
Abstract

Myxomatous mitral valve disease (MMVD) is functionally and histologically identical to mitral valve prolapse (MVP) in humans. Currently, there are no medical treatments that can delay the progression of this valvular disease or associated cardiac remodelling. Therefore, there is a need to understand the molecular pathology associated with MMVD and MVP better, and thus identify potential therapeutic targets. Circulating exosomes contain small RNA, including miRNA, which reflect cell physiology and pathology. This study explored the association between circulating exosomal miRNA (ex-miRNA) content and MMVD, heart failure due to MMVD (MMVD-CHF) and ageing, which is strongly associated with MMVD. Ex-miRNA was isolated from old normal/healthy dogs ( = 6), young normal dogs ( = 7), dogs with MMVD ( = 7) and dogs with MMVD-CHF ( = 7). Separately, total plasma miRNA was isolated from normal dogs ( = 8), dogs with MMVD ( = 8) and dogs with MMVD-CHF ( = 11). Using reverse transcription quantitative polymerase chain reaction, exosomal miR-181c ( = 0.003) and miR-495 ( = 0.0001) significantly increased in dogs with MMVD-CHF compared to the other three groups. Exosomal miR-9 ( = 0.002) increased in dogs with MMVD and MMVD-CHF compared to age-matched (old) normal dogs. Exosomal miR-599 ( = 0.002) decreased in dogs with MMVD compared to old normal dogs. In total plasma, 58 miRNA were deemed significantly different ( < 0.04) between normal dogs, dogs with MMVD and dogs with MMVD-CHF. However, in contrast to ex-miRNA, none of the miRNA in total plasma remained statistically significant if the false discovery rate was <15%. Changes in ex-miRNA are observed in dogs as they age (miR-9, miR-495 and miR-599), develop MMVD (miR-9 and miR-599) and progress from MMVD to CHF (miR-181c and miR-495). Ex-miRNA expression-level changes appear to be more specific to disease states than total plasma miRNA. Elena Aikawa, Harvard Medical School, USA.

摘要

黏液瘤样二尖瓣疾病(MMVD)在功能和组织学上与人类的二尖瓣脱垂(MVP)相同。目前,尚无能够延缓这种瓣膜疾病进展或相关心脏重塑的医学治疗方法。因此,有必要更好地了解与MMVD和MVP相关的分子病理学,从而确定潜在的治疗靶点。循环外泌体含有小RNA,包括miRNA,它们反映细胞的生理和病理状态。本研究探讨了循环外泌体miRNA(ex-miRNA)含量与MMVD、MMVD所致心力衰竭(MMVD-CHF)以及与MMVD密切相关的衰老之间的关联。从老年正常/健康犬(n = 6)、年轻正常犬(n = 7)、患有MMVD的犬(n = 7)和患有MMVD-CHF的犬(n = 7)中分离出ex-miRNA。另外,从正常犬(n = 8)、患有MMVD的犬(n = 8)和患有MMVD-CHF的犬(n = 11)中分离出总血浆miRNA。使用逆转录定量聚合酶链反应,与其他三组相比,患有MMVD-CHF的犬的外泌体miR-181c(P = 0.003)和miR-495(P = 0.0001)显著增加。与年龄匹配的(老年)正常犬相比,患有MMVD和MMVD-CHF的犬的外泌体miR-9(P = 0.002)增加。与老年正常犬相比,患有MMVD的犬的外泌体miR-599(P = 0.002)减少。在总血浆中,正常犬、患有MMVD的犬和患有MMVD-CHF的犬之间有58种miRNA被认为有显著差异(P < 0.04)。然而,与ex-miRNA相反,如果错误发现率<15%,总血浆中的miRNA均无统计学意义。随着犬年龄增长(miR-9、miR-495和miR-599)、发展为MMVD(miR-9和miR-599)以及从MMVD进展为CHF(miR-181c和miR-495),可观察到ex-miRNA的变化。与总血浆miRNA相比,ex-miRNA表达水平的变化似乎对疾病状态更具特异性。 埃琳娜·爱川,美国哈佛医学院

相似文献

1
Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model.在自然发生的犬类模型中,循环外泌体微小RNA与黏液瘤样二尖瓣疾病继发的心力衰竭相关。
J Extracell Vesicles. 2017 Jul 12;6(1):1350088. doi: 10.1080/20013078.2017.1350088. eCollection 2017.
2
Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration.对患有黏液瘤性二尖瓣变性继发充血性心力衰竭的犬进行全基因组测序及循环微RNA定量分析。
Am J Vet Res. 2018 Feb;79(2):163-169. doi: 10.2460/ajvr.79.2.163.
3
Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease.代谢组学分析揭示了黏液样二尖瓣病变犬能量代谢紊乱和氨基酸代谢重编程。
J Am Heart Assoc. 2021 May 4;10(9):e018923. doi: 10.1161/JAHA.120.018923. Epub 2021 Apr 23.
4
Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.患有黏液样二尖瓣疾病的犬的心率、心率变异性和心律失常。
J Vet Intern Med. 2012 Jan-Feb;26(1):76-84. doi: 10.1111/j.1939-1676.2011.00842.x. Epub 2011 Dec 13.
5
Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.健康犬和患有黏液瘤性二尖瓣疾病犬的血浆和血小板血清素浓度。
J Vet Cardiol. 2014 Sep;16(3):155-62. doi: 10.1016/j.jvc.2014.05.003. Epub 2014 Jul 28.
6
Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.犬黏液瘤样二尖瓣疾病中循环微小RNA的表达谱分析
Int J Mol Sci. 2015 Jun 19;16(6):14098-108. doi: 10.3390/ijms160614098.
7
Usefulness of conventional and tissue Doppler echocardiography to predict congestive heart failure in dogs with myxomatous mitral valve disease.传统超声心动图和组织多普勒超声心动图在预测患有黏液瘤样二尖瓣疾病的犬充血性心力衰竭方面的实用性。
J Vet Intern Med. 2015 Jan;29(1):132-40. doi: 10.1111/jvim.12466. Epub 2014 Sep 30.
8
Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019-2021): 98 cases.回顾性评估休克指数在诊断黏液瘤性二尖瓣疾病犬充血性心力衰竭中的作用(2019-2021 年):98 例。
J Vet Emerg Crit Care (San Antonio). 2024 May-Jun;34(3):231-237. doi: 10.1111/vec.13379. Epub 2024 May 29.
9
Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls.与患有心脏杂音的犬只和健康对照相比,继发于黏液瘤性二尖瓣疾病的急性充血性心力衰竭犬的中性粒细胞与淋巴细胞比值升高。
J Am Vet Med Assoc. 2023 Jul 5;261(11):1-8. doi: 10.2460/javma.23.03.0131. Print 2023 Nov 1.
10
Dysregulation of valvular interstitial cell let-7c, miR-17, miR-20a, and miR-30d in naturally occurring canine myxomatous mitral valve disease.自然发生的犬黏液瘤样二尖瓣疾病中瓣膜间质细胞let-7c、miR-17、miR-20a和miR-30d的失调
PLoS One. 2018 Jan 9;13(1):e0188617. doi: 10.1371/journal.pone.0188617. eCollection 2018.

引用本文的文献

1
Exploring the landscape of exosomes in heart failure: a bibliometric analysis.探索心力衰竭中外泌体的研究概况:一项文献计量分析
Int J Surg. 2025 May 1;111(5):3356-3372. doi: 10.1097/JS9.0000000000002248.
2
Involvement of TGF-β, mTOR, and inflammatory mediators in aging alterations during myxomatous mitral valve disease in a canine model.犬粘液瘤样二尖瓣疾病衰老改变中转化生长因子-β、雷帕霉素靶蛋白及炎症介质的作用
Geroscience. 2025 Jan 27. doi: 10.1007/s11357-025-01520-0.
3
Clinical studies in Myxomatous Mitral Valve Disease dogs: most prescribed ACEI inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma.

本文引用的文献

1
Roles of exosomes in cardioprotection.外泌体在心脏保护中的作用。
Eur Heart J. 2017 May 7;38(18):1372-1379. doi: 10.1093/eurheartj/ehw304.
2
miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis.miRNet——通过基于网络的可视化分析剖析微小RNA-靶标相互作用及功能关联。
Nucleic Acids Res. 2016 Jul 8;44(W1):W135-41. doi: 10.1093/nar/gkw288. Epub 2016 Apr 21.
3
Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.Dyrk1a 通过 D 型细胞周期蛋白依赖性 Rb/E2f 信号通路调节心肌细胞周期。
黏液瘤样二尖瓣疾病犬的临床研究:大多数常用的血管紧张素转换酶抑制剂(ACEI)会抑制血管紧张素转换酶2(ACE2)的酶活性,而血管紧张素Ⅱ受体阻滞剂(ARB)会增加血浆中血管紧张素Ⅱ(AngII)的含量。
Hypertens Res. 2025 Apr;48(4):1477-1490. doi: 10.1038/s41440-025-02109-y. Epub 2025 Jan 21.
4
The Role of Cardiac Troponin and Other Emerging Biomarkers Among Athletes and Beyond: Underlying Mechanisms, Differential Diagnosis, and Guide for Interpretation.心肌肌钙蛋白及其他新兴生物标志物在运动员及其他人群中的作用:潜在机制、鉴别诊断及解读指南
Biomolecules. 2024 Dec 19;14(12):1630. doi: 10.3390/biom14121630.
5
Assessing the use of blood microRNA expression patterns for predictive diagnosis of myxomatous mitral valve disease in dogs.评估血液中微小RNA表达模式用于犬黏液瘤样二尖瓣疾病预测诊断的应用。
Front Vet Sci. 2024 Nov 1;11:1443847. doi: 10.3389/fvets.2024.1443847. eCollection 2024.
6
Defining the Role of the miR-145-KLF4-αSMA Axis in Mitral Valvular Interstitial Cell Activation in Myxomatous Mitral Valve Prolapse Using the Canine Model.使用犬模型定义 miR-145-KLF4-αSMA 轴在黏液样二尖瓣脱垂中的二尖瓣瓣环间质细胞激活中的作用。
Int J Mol Sci. 2024 Jan 25;25(3):1468. doi: 10.3390/ijms25031468.
7
Exosomes and their derivatives as biomarkers and therapeutic delivery agents for cardiovascular diseases: Situations and challenges.外泌体及其衍生物作为心血管疾病的生物标志物和治疗递送载体:现状与挑战。
J Transl Int Med. 2023 Dec 20;11(4):341-354. doi: 10.2478/jtim-2023-0124. eCollection 2023 Dec.
8
A review on microRNA detection and expression studies in dogs.犬类微小RNA检测与表达研究综述
Front Vet Sci. 2023 Oct 5;10:1261085. doi: 10.3389/fvets.2023.1261085. eCollection 2023.
9
Extracellular Vesicle MicroRNAs in Heart Failure: Pathophysiological Mediators and Therapeutic Targets.细胞外囊泡 microRNAs 在心力衰竭中的作用:病理生理介质和治疗靶点。
Cells. 2023 Aug 25;12(17):2145. doi: 10.3390/cells12172145.
10
Plasma small extracellular vesicles from dogs affected by cutaneous mast cell tumors deliver high levels of miR-21-5p.患有皮肤肥大细胞瘤的犬血浆中的小细胞外囊泡携带高水平的miR-21-5p。
Front Vet Sci. 2023 Jan 10;9:1083174. doi: 10.3389/fvets.2022.1083174. eCollection 2022.
Cardiovasc Res. 2016 Jun 1;110(3):381-94. doi: 10.1093/cvr/cvw074. Epub 2016 Apr 7.
4
miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy.miR-410和miR-495在多种心肌病中受到动态调控,抑制它们可减轻病理性肥大。
PLoS One. 2016 Mar 21;11(3):e0151515. doi: 10.1371/journal.pone.0151515. eCollection 2016.
5
MicroRNA-9 regulates cardiac fibrosis by targeting PDGFR-β in rats.微小RNA-9通过靶向大鼠血小板衍生生长因子受体-β调控心脏纤维化。
J Physiol Biochem. 2016 Jun;72(2):213-23. doi: 10.1007/s13105-016-0471-y. Epub 2016 Feb 19.
6
Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers.接受β受体阻滞剂治疗的冠状动脉搭桥手术后心房组织中术后房颤的基因特征。
J Mol Cell Cardiol. 2016 Mar;92:109-15. doi: 10.1016/j.yjmcc.2016.02.006. Epub 2016 Feb 6.
7
Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function.心肌细胞KLF5调节过氧化物酶体增殖物激活受体α(Ppara)的表达及心脏功能。
Circ Res. 2016 Jan 22;118(2):241-53. doi: 10.1161/CIRCRESAHA.115.306383. Epub 2015 Nov 16.
8
miR-599 Inhibits Vascular Smooth Muscle Cells Proliferation and Migration by Targeting TGFB2.微小RNA-599通过靶向转化生长因子β2抑制血管平滑肌细胞增殖和迁移。
PLoS One. 2015 Nov 9;10(11):e0141512. doi: 10.1371/journal.pone.0141512. eCollection 2015.
9
Akt-dependent Girdin phosphorylation regulates repair processes after acute myocardial infarction.Akt 依赖的 Girdin 磷酸化调节急性心肌梗死后的修复过程。
J Mol Cell Cardiol. 2015 Nov;88:55-63. doi: 10.1016/j.yjmcc.2015.09.012. Epub 2015 Sep 21.
10
Predicting effective microRNA target sites in mammalian mRNAs.预测哺乳动物mRNA中有效的微小RNA靶位点。
Elife. 2015 Aug 12;4:e05005. doi: 10.7554/eLife.05005.